Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Wilson

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|February 27, 2013
Non-nucleoside inhibitors of BasE, an adenylating enzyme in the siderophore biosynthetic pathway of the opportunistic pathogen Acinetobacter baumanniiJoão Neres, Curtis A Engelhart, Eric J Drake, et al.
Bioinformatics (Oxford, England)|January 29, 2019
DeepAMR for predicting co-occurrent resistance of Mycobacterium tuberculosisYang Yang, Timothy M Walker, A Sarah Walker, et al.
The American Journal of Cardiology|March 31, 2012
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study)Jennifer E Ho, David D Waters, Allison Kean, et al.
Plos Genetics|September 27, 2008
Tracing the source of campylobacteriosisDaniel J Wilson, Edith Gabriel, Andrew J H Leatherbarrow, et al.
Mayo Clinic Proceedings|August 5, 2008
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney diseaseJames Shepherd, John P Kastelein, Vera A Bittner, et al.
European Journal of Medicinal Chemistry|July 23, 2018
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase HLei Wang, Jing Tang, Andrew D Huber, et al.
Journal of Medicinal Chemistry|December 19, 2014
Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activitiesSanjeev Kumar V Vernekar, Zheng Liu, Eva Nagy, et al.
European Journal of Medicinal Chemistry|February 12, 2019
Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linkerJing Tang, Ha T Do, Andrew D Huber, et al.
Journal of the American Chemical Society|October 13, 2011
Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosisCe Shi, Todd W Geders, Sae Woong Park, et al.
Journal of Medicinal Chemistry|August 12, 2008
Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosineJoão Neres, Nicholas P Labello, Ravindranadh V Somu, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|February 27, 2013
Non-nucleoside inhibitors of BasE, an adenylating enzyme in the siderophore biosynthetic pathway of the opportunistic pathogen Acinetobacter baumanniiJoão Neres, Curtis A Engelhart, Eric J Drake, et al.
Bioinformatics (Oxford, England)|January 29, 2019
DeepAMR for predicting co-occurrent resistance of Mycobacterium tuberculosisYang Yang, Timothy M Walker, A Sarah Walker, et al.
The American Journal of Cardiology|March 31, 2012
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study)Jennifer E Ho, David D Waters, Allison Kean, et al.
Plos Genetics|September 27, 2008
Tracing the source of campylobacteriosisDaniel J Wilson, Edith Gabriel, Andrew J H Leatherbarrow, et al.
Mayo Clinic Proceedings|August 5, 2008
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney diseaseJames Shepherd, John P Kastelein, Vera A Bittner, et al.
European Journal of Medicinal Chemistry|July 23, 2018
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase HLei Wang, Jing Tang, Andrew D Huber, et al.
Journal of Medicinal Chemistry|December 19, 2014
Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activitiesSanjeev Kumar V Vernekar, Zheng Liu, Eva Nagy, et al.
European Journal of Medicinal Chemistry|February 12, 2019
Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linkerJing Tang, Ha T Do, Andrew D Huber, et al.
Journal of the American Chemical Society|October 13, 2011
Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosisCe Shi, Todd W Geders, Sae Woong Park, et al.
Journal of Medicinal Chemistry|August 12, 2008
Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosineJoão Neres, Nicholas P Labello, Ravindranadh V Somu, et al.
Pageof 20